Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

391 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Continuing anti-EGFR monoclonal antibody after secondary resection significantly prolongs overall survival for patients with metastatic colorectal cancer who were responsive to first-line anti-EGFR monoclonal antibody plus chemotherapy doublet.
Hsieh YY, Su YL, Kuan FC, Chen SG, Chang CL, Shao YY, Tsai CW, Liang YH. Hsieh YY, et al. Among authors: liang yh. Am J Cancer Res. 2024 Dec 15;14(12):5909-5920. doi: 10.62347/MUCQ4129. eCollection 2024. Am J Cancer Res. 2024. PMID: 39803663 Free PMC article.
Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer: a nationwide registry.
Chen CC, Chang SC, Chang YY, Lin BW, Chen HH, Hsieh YY, Hsu HC, Hsieh MC, Ke TW, Kuan FC, Wu CC, Lu WC, Su YL, Liang YH, Chen JB, Huang HY, Tsai HL, Wang JY. Chen CC, et al. Among authors: liang yh. Am J Cancer Res. 2023 Dec 15;13(12):6333-6345. eCollection 2023. Am J Cancer Res. 2023. PMID: 38187069 Free PMC article.
Outcomes of upfront primary tumor resection in patients with synchronous RAS wild-type metastatic colorectal cancer.
Chen PJ, Chen CC, Chang SC, Chang YY, Lin BW, Chen HH, Hsieh YY, Hsu HC, Hsieh MC, Ke TW, Kuan FC, Wu CC, Lu WC, Su YL, Liang YH, Chen JB, Huang SY, Huang CW, Wang JY. Chen PJ, et al. Among authors: liang yh. Am J Cancer Res. 2024 Dec 15;14(12):5863-5873. doi: 10.62347/DLWI1455. eCollection 2024. Am J Cancer Res. 2024. PMID: 39803657 Free PMC article.
Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study.
Chang YT, Chen CC, Chang SC, Chang YY, Lin BW, Chen HH, Hsieh YY, Hsu HC, Hsieh MC, Kuan FC, Wu CC, Lu WC, Su YL, Liang YH, Chen JB, Huang SY, Huang CW, Wang JY. Chang YT, et al. Among authors: liang yh. Nutrients. 2023 Jun 30;15(13):2971. doi: 10.3390/nu15132971. Nutrients. 2023. PMID: 37447297 Free PMC article.
Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment.
Chen HH, Ke TW, Huang CW, Jiang JK, Chen CC, Hsieh YY, Teng HW, Lin BW, Liang YH, Su YL, Hsu HC, Kuan FC, Chou YH, Lin J, Lin BR, Chang YY, Wang JY. Chen HH, et al. Among authors: liang yh. Front Oncol. 2021 Nov 15;11:764912. doi: 10.3389/fonc.2021.764912. eCollection 2021. Front Oncol. 2021. PMID: 34868987 Free PMC article. Review.
391 results